[go: up one dir, main page]

FI922867A - Dikarbonsyraderivat och foerfarande foer framstaellning av dem - Google Patents

Dikarbonsyraderivat och foerfarande foer framstaellning av dem Download PDF

Info

Publication number
FI922867A
FI922867A FI922867A FI922867A FI922867A FI 922867 A FI922867 A FI 922867A FI 922867 A FI922867 A FI 922867A FI 922867 A FI922867 A FI 922867A FI 922867 A FI922867 A FI 922867A
Authority
FI
Finland
Prior art keywords
dicarbony
framstaellning
farms
dem
differential
Prior art date
Application number
FI922867A
Other languages
English (en)
Other versions
FI922867A0 (fi
Inventor
Ken-Ichi Nunami
Tameo Iwasaki
Kazuo Matsumoto
Koji Yano
Isao Yamaguchi
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of FI922867A0 publication Critical patent/FI922867A0/fi
Publication of FI922867A publication Critical patent/FI922867A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
FI922867A 1991-06-21 1992-06-18 Dikarbonsyraderivat och foerfarande foer framstaellning av dem FI922867A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24715591 1991-06-21

Publications (2)

Publication Number Publication Date
FI922867A0 FI922867A0 (fi) 1992-06-18
FI922867A true FI922867A (fi) 1992-12-22

Family

ID=17159257

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922867A FI922867A (fi) 1991-06-21 1992-06-18 Dikarbonsyraderivat och foerfarande foer framstaellning av dem

Country Status (10)

Country Link
US (1) US5312826A (fi)
EP (1) EP0519738A1 (fi)
KR (1) KR930000491A (fi)
CN (1) CN1068110A (fi)
AU (1) AU649546B2 (fi)
CA (1) CA2071659A1 (fi)
FI (1) FI922867A (fi)
IE (1) IE921994A1 (fi)
IL (1) IL102264A0 (fi)
TW (1) TW207993B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06199850A (ja) * 1992-12-28 1994-07-19 Tanabe Seiyaku Co Ltd インドール含有ペプチド及びその製法
US5563277A (en) * 1994-12-21 1996-10-08 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
EP0928790B1 (en) * 1998-01-02 2003-03-05 F. Hoffmann-La Roche Ag Thiazole derivatives
US6100282A (en) 1998-01-02 2000-08-08 Hoffman-La Roche Inc. Thiazole derivatives
CA2339666A1 (en) 1998-08-07 2000-02-17 Smithkline Beecham Corporation Vitronectin receptor antagonists
US7045653B2 (en) 2002-12-23 2006-05-16 Pfizer, Inc. Pharmaceuticals
NZ535969A (en) 2004-10-15 2006-07-28 Garth Kennedy Mcgregor Wastewater heat recovery
JP2012526810A (ja) 2009-05-13 2012-11-01 イントラ−セルラー・セラピーズ・インコーポレイテッド 有機化合物
JP6549040B2 (ja) 2013-02-17 2019-07-24 イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−Ｃｅｌｌｕｌａｒ Ｔｈｅｒａｐｉｅｓ， Ｉｎｃ． 新規使用
US10131671B2 (en) 2014-08-07 2018-11-20 Intra-Cellular Therapies, Inc. Organic compounds
WO2017172795A1 (en) 2016-03-28 2017-10-05 Intra-Cellular Therapies, Inc. Novel compositions and methods
WO2019152697A1 (en) 2018-01-31 2019-08-08 Intra-Cellular Therapies, Inc. Novel uses

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2538963A (en) * 1945-12-21 1951-01-23 Squibb & Sons Inc Preparation of cupric d-penicilloate-g
US2491523A (en) * 1946-11-08 1949-12-20 Merck & Co Inc Chemical compounds and processes for preparing them
US3804820A (en) * 1971-03-11 1974-04-16 K Vogler N-(substituted-alpha-penicilloyl)-amino carboxylic acids
US4313945A (en) * 1978-11-23 1982-02-02 Ciba-Geigy Corporation 7-Thiazolyl-acetamido-cephem derivatives with terminal aminocarboxylic acid grouping
US4331806A (en) * 1979-07-30 1982-05-25 E. R. Squibb & Sons, Inc. Dithioacyldihydropyrazole carboxylic acid derivatives
GB2065643B (en) * 1979-12-13 1983-08-24 Kanegafuchi Chemical Ind Optically active n-mercaptoalkanoylamino acids
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
IT1195287B (it) * 1981-11-05 1988-10-12 Ausonia Farma Srl Derivato tiazolico,procedimento per la sua preparazione e relative composizioni farmaceutiche
US4483850A (en) * 1982-05-10 1984-11-20 Merck & Co., Inc. N-Terminal substituted oligopeptide converting enzyme inhibitors
US4524212A (en) * 1982-09-27 1985-06-18 E. R. Squibb & Sons, Inc. Acyloxyketone substituted imino and amino acids
US4602002A (en) * 1983-02-07 1986-07-22 Merck & Co., Inc. N-carboxymethyl substituted lysyl and α-(ε-aminoalkyl) glycyl amino acid antihypertensive agents
EP0254032A3 (en) * 1986-06-20 1990-09-05 Schering Corporation Neutral metalloendopeptidase inhibitors in the treatment of hypertension
US4749688A (en) * 1986-06-20 1988-06-07 Schering Corporation Use of neutral metalloendopeptidase inhibitors in the treatment of hypertension
FR2623498B1 (fr) * 1987-11-24 1990-04-06 Bioprojet Soc Civ Nouveaux composes enantiomeres derives d'amino-acides, leur procede de preparation et leurs applications therapeutiques

Also Published As

Publication number Publication date
IE921994A1 (en) 1992-12-30
EP0519738A1 (en) 1992-12-23
TW207993B (fi) 1993-06-21
IL102264A0 (en) 1993-01-14
CN1068110A (zh) 1993-01-20
KR930000491A (ko) 1993-01-15
FI922867A0 (fi) 1992-06-18
CA2071659A1 (en) 1992-12-22
AU649546B2 (en) 1994-05-26
US5312826A (en) 1994-05-17
AU1838592A (en) 1992-12-24

Similar Documents

Publication Publication Date Title
FI935074A (fi) Nya tiopyranopyrrolderivat och framstaellning av dem
FI912075A (fi) Haorbehandlingskomposition i form av en mikroemulsion och foerfarande foer framstaellning och anvaendning av densamma.
FI906444A0 (fi) Paofyllbar polyesterkaerl och foer form foer bildande av detta.
FI922564A0 (fi) Foerfarande foer bestaemning av utjaemningsfoerdroejningar i oeverfoeringssystem och motsvarande oever- foeringssystem.
FI914611A0 (fi) 2-aminopyrimidin-4 -karboxamidderivat, framstaellning och terapeutisk anvaendning av dem.
FI922867A (fi) Dikarbonsyraderivat och foerfarande foer framstaellning av dem
FI933544A (fi) Tiadiazinkarboxamidderivat, foerfaranden foer framstaellning av dem och laekemedel
FI922168A0 (fi) Foerfarande och anordning foer ultrasonisk provning av kaernkraftbraensleelement under anvaendning av en passtyrning.
FI921814A (fi) 2-aminopyrimidin-4-karboxiamidderivat, deras framstaellning och terapeutisk anvaendning av dem
FI922389A0 (fi) Anordning foer framstaellning av en pressmantel avsedd foer bruk i pappersindustrin och pressmantel framstaelld daermed.
FI932750A0 (fi) Kaoda nedbrytande svampar och preparation av dem
FI915281A0 (fi) Expanderbara och expanderade partiklar och foerfarande foer framstaellning av dem.
FI923156A (fi) Nya kefalosporinfoereningar och foerfaranden foer framstaellning av dem.
FI924281A (fi) Tienocyklopentanonoximers etrar, deras framstaellning och farmaceutiskasammansaettningar innehaollande dem
FI913357A0 (fi) Foerfarande och form foer framstaellning av en straengsprutad elektronikmodul.
FI885643A0 (fi) Anordning foer lastning av foeremaol pao en vagntransportoer och foer lossning av dem fraon denna.
FI935170A (fi) Nya kiralsulfater, framstaellning av dem och anvaendning i syntesen av farmaceutiska foereningar
FI906118A0 (fi) Foerfarande och form foer gjutning av plattbelaeggning.
FI915890A0 (fi) Sakkaridfoereningar metoder och apparat foer syntes av dem.
FI910202A0 (fi) Saett och anordning foer maetning av en kvarns fyllningsgrad.
FI951242A0 (fi) Foerfarande foer framstaellning av polucykliska aminfoereningar och enantiomerer daerav
FI881318A0 (fi) Transportbehaollare foer olika vaetskor och foerfarande foer utnyttjande av dem.
FI905462A0 (fi) Anordning foer torkning och behandling av kott.
FI914465A0 (fi) Anordning foer underlaettande av rivning och sanering av hoega byggnader.
FI910301A0 (fi) Anvaendning av ic-krets och daertill ansluten ljudaotergivningsanordning foer talkommunikation i olika foerpackningar.

Legal Events

Date Code Title Description
FD Application lapsed